参考文献/References:
[1] 陈伟伟,高润霖,刘力生,等.《中国心血管病报告2017》概要[J].中国循环杂志,2018,33(1):1-8.
[2] Ponikowski P,Voors AA,Anker SD,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J]. Eur J Heart Fail,2016,18(8):891-975.
[3] 任小田. 射血分数保留的心力衰竭的研究进展[J]. 心血管病学进展,2018,39(6):987-990.
[4] Pandey A,Parashar A,Kumbhani D,et al. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials[J]. Circ Heart Fail,2015,8(1):33-40.
[5] Pearson MJ,Mungovan SF,Smart NA. Effect of exercise on diastolic function in heart failure patients: a systematic review and meta-analysis[J]. Heart Fail Rev,2017,22(2):229-242.
[6] Montero D,Diaz-Ca?estro C.Determinants of exercise intolerance in heart failure with preserved ejection fraction: a systematic review and meta-analysis[J].Int J Cardiol,2018,254:224-229.
[7] Haykowsky MJ, Brubaker PH, Stewart KP,et al. Eeffect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction[J]. J Am Coll Cardiol,2012,60(2):120-128.
[8] Bowen TS, Rolim NPL,Fischer T,et al. Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle[J]. Eur J Heart Fail,2015,17(3):263-272.
[9] Paulus WJ,Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation[J]. J Am Coll Cardiol,2013,62(4):263-271.
[10] Tanaka S, Sanuki Y, Ozumi K, et al. Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation: impact of endothelial function[J]. Heart and Vessels,2018,33(8):886-892.
[11] Brubaker PH, Kitzman DW. Chronotropic incompetence[J]. Circulation,2011,123(9):1010-1020.
[12] Imai K,Sato H,Hori M,et al. Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure[J]. J Am Coll Cardiol,1994,24(6):1529-1535.
[13] Phan TT, Shivu GN, Abozguia K,et al. Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction[J]. Circ Heart Fail,2010,3(1):29-34.
[14] Gulgun M. Heart Rate Variability, Heart rate recovery, and heart rate turbulence represent different components of the cardiac autonomic nervous system[J]. Med Princ Pract,2017,26(1):98-99.
[15] Disertori M,Mase M,Rigoni M,et al. Heart rate turbulence is a powerful predictor of cardiac death and ventricular arrhythmias in postmyocardial infarction and heart failure patients: a systematic review and meta-analysis[J]. Circ Arrhythm Electrophysiol,2016,9(12).pii:e004610
[16] Piotrowicz E,Baranowski R,Piotrowska M,et al. Variable effects of physical training of heart rate variability, heart rate recovery, and heart rate turbulence in chronic heart failure[J]. Pacing Clin Electrophysiol,2009,32 Suppl 1:S113-S115.
[17] O’Connor CM,Whellan DJ,Lee KL,et al. Efficacy and safety of exercise training in patients with chronic heart failure[J]. JAMA,2009,301(14):1439.
[18] Edelmann F,Bobenko A,Gelbrich G,et al. Exercise training in diastolic heart failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial[J]. Eur J Heart Fail,2017,19(8):1067-1074.
[19] 中国康复医学会心血管病专业委员会. 中国心脏康复与二级预防指南2018精要[J]. 中华内科杂志,2018,57(11):802-810.
[20] Fletcher GF, Ades PA, Kligfield P,et al. Exercise standards for testing and training: a scientific statement from the American Heart Association[J]. Circulation,2013,128(8):873-934.
[21] Balady GJ,Williams MA,Ades PA,et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation,and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention,and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation[J]. Circulation,2007,115(20):2675-2682.
[22] Piepoli MF, Corra U,Benzer W,et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the cardiac rehabilitation section of the European Association of Cardiovascular Prevention and Rehabilitation[J]. Eur J Cardiovasc Prev Rehabil,2010,17(1):1-17.
[23] 中华医学会心血管病学分会，中国康复医学会心血管病专业委员会，中国老年学学会心脑血管病专业委员会. 冠心病康复与二级预防中国专家共识[J]. 中华心血管病杂志,2013,41(4):267-275.
[24] Uddin J,Zwisler AD,Lewinter C,et al. Predictors of exercise capacity following exercise-based rehabilitation in patients with coronary heart disease and heart failure: a meta-regression analysis[J]. Eur J Prev Cardiol,2016,23(7):683-693.
[25] Angadi SS,Mookadam F,Lee CD,et al. High-intensity interval training vs. moderate-intensity continuous exercise training in heart failure with preserved ejection fraction: a pilot study[J]. J Appl Physiol(1985),2015,119(6):753-758.
[26] Hambrecht R,Niebauer J,Marburger C,et al. Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions[J]. J Am Coll Cardiol,1993,22(2):468-477.
[27] Aragam KG,Dai D,Neely ML,et al. Gaps in referral to cardiac rehabilitation of patients undergoing percutaneous coronary intervention in the United States[J]. J Am Coll Cardiol,2015,65(19):2079-2088.
[28] Pirruccello JP, Traynor KC, Natarajan P,et al. An electronic cardiac rehabilitation referral system increases cardiac rehabilitation referrals[J]. Coron Artery Dis,2017,28(4):342-345.
[29] 胡大一. 我国心脏康复的困局、机遇及十年规划[J]. 中华全科医师杂志,2014,5(13):329-330.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(8):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(8):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(8):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(8):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(8):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(8):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]唐欣 罗素新.心房颤动合并 射血分数保留的心力衰竭的研究进展[J].心血管病学进展,2019,(5):753.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.022]
TANG Xin,LUO Suxin.Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2019,(8):753.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.022]
[9]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(8):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[10]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(8):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]